Poland· PL-100488712
Elidel
A pimecrolimus product containing pimecrolimusum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pimecrolimus is registered in 13 of 19 countries.
Countries holding a registration under ATC D11AH02 (pimecrolimus), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Pimecrolimus · ATC D11AH02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Pimecrolimusum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- D11AH02
- ATC class
- Pimecrolimus
- Defined daily dose
- 20 mg, T
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991524036
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
217 interactions on record for pimecrolimus.
Graded by severity as the source publishes them — 9 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pimecrolimus · interactions on record
217 records
- 9 moderate
- 83 minor
- 125 info
Most severe, free to view
- FostamatinibB02BX09moderate
- EchinaceaD03AH02moderate
- TemsirolimusL01EG01moderate
- SirolimusL01EG04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pimecrolimus in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatespimecrolimusActavis Pharma, Inc.
- CzechiaELIDELVIATRIS HEALTHCARE LIMITED, Dublin
- FinlandElidelParanova Oy
- SwedenElidel 10 mg/g KrämViatris AB
- IcelandElidelViatris ApS
- NetherlandsElidel 10 mg/g, crèmeViatris Healthcare Limited
- NorwayElidelViatris AS
- SpainELIDEL 10 mg/g CREMAViatris Healthcare Limited
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Elidel
- Belgium · Elidel
- Bulgaria · Елидел
- Cyprus · Elidel
- Czechia · Elidel
- Germany · Elidel
- Denmark · Elidel
- Estonia · Elidel
- Spain · Elidel
- Finland · Elidel
- United Kingdom (Northern Ireland) · Elidel
- Greece · Elidel
- Croatia · Elidel
- Hungary · Elidel
- Iceland · Elidel
- Italy · Elidel
- Lithuania · Elidel
- Luxembourg · Elidel
- Latvia · Elidel
- Malta · Elidel
- Netherlands · Elidel
- Norway · Elidel
- Portugal · Elidel
- Romania · Elidel
- Sweden · Elidel
- Slovenia · Elidel
- Slovakia · Elidel
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/463f6b29-3512-4bed-8e72-035ff500c907 GET /v1/drugs/463f6b29-3512-4bed-8e72-035ff500c907?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "urpl",
"strength": "10 mg/g",
"packaging": "05909991524036 ¦ Rp ¦ 151742\n1 tuba 15 g",
"substance": "Pimecrolimusum 10 mg/g",
"common_name": "Pimecrolimusum",
"pl_product_id": "100488712",
"pozwolenie_nr": "231/23",
"auth_procedure": "IR",
"authorisation_validity": "2028-10-13"
}See everything about pimecrolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.